<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, RDV is tested in multiple ongoing phase 3 clinical trials for COVID-19 treatment (NCT04252664, NCT04257656, NCT04292730, NCT04292899, NCT04280705, Solidarity trial (WHO); DisCoVeRy trial (INSERM) in Belgium, and so on) and The European Medicine Agency (EMA) adopted Article 83, which provides recommendations on compassionate use of RDV for COVID-19 treatment in the European Union [
 <xref rid="B73-jcm-09-02084" ref-type="bibr">73</xref>].
</p>
